XML 48 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended 115 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (4,016,746) $ (3,260,225) $ (15,745,207)
Adjustments to reconcile net loss to net cash used by operating activities      
Depreciation and amortization 24,450 40,804 255,988
Non-cash fair value of common stock issued for consulting 110,500    133,988
Share-based compensation related to employee stock options 544,503 1,569,037 2,684,947
Amortization of debt discount    8,646 19,292
Non-cash fair value of stock options issued to non-employees for consulting 8,787    1,374,752
Non-cash fair value of warrants issued to non-employees for consulting 134,420    134,420
Expenses paid by issuance of preferred stock/ common stock 70,000    247,650
Loss on fixed asset dispositions 1,145    72,695
Gain on debt and accounts payable settlement (133,142) (124,889) (1,616,158)
Loss on early extinguishment of debt    61,419 61,419
(Increase) decrease in:      
Accounts receivable       50,000
Prepaid expenses (27,019) (34,526) (77,310)
Increase (decrease) in:      
Accounts payable (56,090) (318,211) 650,029
Accrued expenses 58,496 (222,051) 593,510
Net Cash Used by Operating Activities (3,280,696) (2,279,996) (11,159,985)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Cash paid for intangible assets    (22,500) (161,609)
Net cash received in acquisition    69 69
Cash paid for purchase of property and equipment (40,929) (163,424) (412,972)
Net Cash Used by Investing Activities (40,929) (185,855) (574,512)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from issuance of notes - stockholder       1,400,000
Proceeds from issuance of short-term convertible notes    195,000 608,165
Advances from stockholders       679,500
Proceeds from sale of common stock, net 1,360,572 4,129,579 8,430,920
Proceeds from sale of preferred stock, net    1,395,000 1,920,000
Net Cash Provided by Financing Activities 1,360,572 5,719,579 13,038,585
Net Increase (Decrease) in Cash and Cash Equivalents (1,961,053) 3,253,728 1,304,088
Cash and Cash Equivalents, Beginning of Period 3,265,141 11,413   
Cash and Cash Equivalents, End of Period 1,304,088 3,265,141 1,304,088
Supplemental Cash Flow Disclosures:      
Interest expense paid in cash         
Income tax paid         
Supplemental Non-Cash Disclosure:      
Conversion of preferred stock to common stock       288
Notes payable - stockholder - settled in common stock    735,000 2,135,000
Accrued interest - stockholder - settled in common stock    78,680 188,569
Preferred Stock Dividend (167,945) (977,388) (1,145,333)
Advances from stockholders settled in common stock       679,500
Accounts payable settled in common stock    367,600 471,472
Accounts payable settled in common stock options       30,500
Accrued expenses settled in common stock options       3,000
Decrease in accounts payable related to fixed asset disposition       133,314
Decrease in accounts payable related to settlement 133,142 124,889 1,616,158
Decrease in accrued expenses related to settlement       3,000
Increase in accounts receivable related to common stock issuance       50,000
Warrants issued with convertible notes payable    $ 7,474 $ 7,474